May 31, 2018 - More people than ever are being diagnosed with diabetes, and big advances in treatment could make these diabetes stocks savvy investments.
May 30, 2018 - Names on the move ahead of the open.
May 30, 2018 - Novo Nordisk's (NVO) oral formulation of Ozempic acts better in lowering blood sugar levels in adults with type II diabetes than Eli Lilly's Jardiance, in the second phase IIIa study, PIONEER 2.
May 25, 2018 - Here's everything you need to know about investing in the fast-growing diabetes market.
May 18, 2018 - Top Research Reports for Walmart, AT&T & Novo Nordisk
May 07, 2018 - Sales of older medications are on the decline, but newer medications helped the revenue line grow at constant exchange rates.
May 03, 2018 - NVO earnings call for the period ending March 31, 2018.
May 02, 2018 - Novo Nordisk A/S (NYSE:NVO)Q1 2018 Earnings CallMay 02, 2018 7:00 am ETExecutivesLars Fruergaard Jørgensen - Novo Nordisk A/SMads Krogsgaard Thomsen - Novo Nordisk A/SKarsten Munk Knudsen - Novo Nordi
May 02, 2018 - Novo Nordisk's (NVO) first-quarter 2018 results beat earnings, but missed on revenue estimates.
Apr 24, 2018 - Enanta Pharmaceuticals helped AbbVie score big last year. Now it's setting its sights even higher.